Skip to main content
. 2019 Oct 21;19:972. doi: 10.1186/s12885-019-6185-0

Fig. 4.

Fig. 4

Enzalutamide inhibits androgen biosynthetic enzyme expression in bone tumors. a Westernblot analysis of VCaP scr shRNA and VCaP ERG shRNA tumors. b Quantitation of ERG, AR, AKR1C3, HSD3B1 and HSD3B2 in bone tumors